Leila Alland's Insider Trades & SAST Disclosures

Leila Alland's most recent trade in Abeona Therapeutics Inc was a trade of 36,101 Common Stock done . Disclosure was reported to the exchange on Jan. 31, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Abeona Therapeutics Inc
Leila Alland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 36,101 154,366 (0%) 0% 0 Common Stock
Abeona Therapeutics Inc
Leila Alland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2024 11,797 118,265 (0%) 0% 0 Common Stock
Abeona Therapeutics Inc
Leila Alland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jul 2024 23,611 106,468 (0%) 0% 0 Common Stock
Abeona Therapeutics Inc
Leila Alland Director Purchase of securities on an exchange or from another person at price $ 4.71 per share. 16 May 2024 11,000 82,857 (0%) 0% 4.7 51,799 Common Stock
Abeona Therapeutics Inc
Leila Alland Director Grant, award, or other acquisition of securities at price $ 4.62 per share. 14 Jun 2023 58,689 79,103 (0%) 0% 4.6 271,143 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2023 100,000 100,000 - - Employee Stock Option (right to buy)
Abeona Therapeutics Inc
Leila Alland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2022 13,400 20,414 (0%) 0% 0 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Sep 2022 52,200 52,200 - 0 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 104,400 104,400 - - Employee Stock Option (right to buy)
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 30.25 per share. 09 Sep 2021 100 0 - 30.3 3,025 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Sep 2021 100 353,850 - - Employee Stock Option (right to buy)
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. 09 Sep 2021 100 100 - 3.9 390 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 30.25 per share. 07 Sep 2021 3,900 0 - 30.3 117,975 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Sep 2021 3,900 353,950 - - Employee Stock Option (right to buy)
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. 07 Sep 2021 3,900 3,900 - 3.9 15,210 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Aug 2021 4,000 357,850 - - Employee Stock Option (right to buy)
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. 09 Aug 2021 4,000 4,000 - 3.9 15,600 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 35.06 per share. 09 Aug 2021 2,198 1,802 - 35.1 77,070 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 32.66 per share. 09 Aug 2021 2,049 224 - 32.7 66,914 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 36.69 per share. 09 Aug 2021 224 0 - 36.7 8,219 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. 07 Jul 2021 4,000 4,000 - 3.9 15,600 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jul 2021 4,000 361,850 - - Employee Stock Option (right to buy)
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 32.66 per share. 07 Jul 2021 2,049 0 - 32.7 66,914 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 31.93 per share. 07 Jul 2021 1,951 2,049 - 31.9 62,300 Common Stock
Abeona Therapeutics Inc
Leila Alland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2021 98,168 98,168 - - Stock Option (right to buy)
Abeona Therapeutics Inc
Leila Alland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2021 77,181 77,181 (0%) 0% 0 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2021 36,279 36,279 - - Employee Stock Option (right to buy)
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 May 2021 4,000 365,850 - - Employee Stock Option (right to buy)
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. 12 May 2021 4,000 4,000 - 3.9 15,600 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 33.39 per share. 12 May 2021 2,633 1,367 - 33.4 87,903 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 34.00 per share. 12 May 2021 1,367 0 - 34.0 46,484 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2021 4,000 369,850 - - Employee Stock Option (right to buy)
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. 07 May 2021 4,000 4,000 - 3.9 15,600 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 34.80 per share. 07 May 2021 3,842 158 - 34.8 133,702 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 35.49 per share. 07 May 2021 158 0 - 35.5 5,607 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Apr 2021 4,000 373,850 - - Employee Stock Option (right to buy)
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. 07 Apr 2021 4,000 4,000 - 3.9 15,600 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 33.86 per share. 07 Apr 2021 3,972 28 - 33.9 134,481 Common Stock
PMV Pharmaceuticals Inc
Leila Alland Chief Medical Officer Sale of securities on an exchange or to another person at price $ 34.43 per share. 07 Apr 2021 28 0 - 34.4 964 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades